Company Active LTD

Company profile

Hello Bio Limited

Hello Bio | Antagonists, inhibitors, antibodies, fluorescent tools

High quality reagents for receptor, ion channel and enzyme research including antagonists, agonists, antibodies, fluorescent tools from Hello Bio - a trusted, affordable life science reagents supplier.

CRN
08891750
Founded
2014
Age
12

Overview

Legal name
HELLO BIO LIMITED
Region
South West England
Registered address
UNIT 3 IO CENTRE, CABOT PARK
MOOREND FARM AVENUE
AVONMOUTH
BRISTOL
ENGLAND
BS11 0QL
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
13

Company events

Reference milestones and recent Companies House filing stream events.

7 events
26 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

12 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Feb
2025

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ1NjMxNTUzM2FkaXF6a2N4

Published 25 Feb 2025 11:20

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

20 Sep
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNjcxMzYyOWFkaXF6a2N4

Published 20 Sep 2024 04:29

12 Feb
2014

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2021
Funded years
2021, 2024
Age at first award
7 years

Projects

2024 Knowledge Transfer Partnership

University of Bristol and Hello Bio Limited KTP 23_24 R1

22 Mar 2024 to 22 Mar 2027

Awarded
£0
Total cost £0

To develop new processes to manufacture novel, conjugated-immunochemical products for life science researchers to improve fundamental research into cancer, cell biology and immunology.

2021 Knowledge Transfer Partnership

University of Bristol and Hello Bio Limited

1 May 2021 to 31 Aug 2023

Awarded
Unknown

To bring novel, uniquely-validated research antibodies to scientists worldwide, improve quality standards in the industry, and advance research into Alzheimer’s Disease, neurodegeneration, stroke and epilepsy.

Product types

Knowledge Transfer Partnership